Add Company
Join Now

Dorian Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Dorian Therapeutics's estimated annual revenue is currently $1.7M per year.(i)
  • Dorian Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Dorian Therapeutics has 11 Employees.(i)
  • Dorian Therapeutics grew their employee count by 0% last year.

Dorian Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder and CSOReveal Email/Phone
2
VP ChemistryReveal Email/Phone
3
Lab ManagerReveal Email/Phone
4
Senior ScientistReveal Email/Phone
5
Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Dorian Therapeutics?

Dorian Therapeutics is an anti-aging company developing senoblockers, a new class of therapeutics with a double function: blocking senescence while reactivating the regeneration capacity of a tissue.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Dorian Therapeutics News

2022-04-06 - U.Va. Health joins national study analyzing mild-to-moderate ...

They initially focused on hospital-based therapies as a part of the Adaptive ... Alban Gaultier and former graduate student Dorian Rosen.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M12-20%N/A
#2
$1.9M120%N/A
#3
$1M1330%N/A
#4
$1.2M140%N/A
#5
$1.1M14-7%N/A